Is the Chinese name of the targeted drug adagrasib adagrasib?

Targeted drugThe Chinese name of Adagrasib is Adagrasib. Adagrasib is a highly efficient and selective small molecule inhibitor targeting KRAS G12C mutations. It inhibits the proliferation and spread of tumor cells by directly inhibiting the activity of KRAS G12C protein and blocking the conduction of its downstream signaling pathways. This drug has demonstrated good efficacy and safety in clinical trials, providing a new treatment option for cancer patients carrying KRAS G12C mutations. As a prescription drug, adagrasib must be used under the guidance of a doctor. Before using adagrasiib, patients should fully understand the indications, usage and dosage, adverse reactions and other information of the drug, and use the drug strictly in accordance with the doctor's instructions.